[1]
E. Shahverdi, H. Abolghasemi, A. Shahverdi, S. Kamali, and S. M. Hosseini, “Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors: A Narrative Clinical Review”, Asian Pac J Cancer Biol, vol. 11, no. 2, pp. 695–703, Jun. 2026.